Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Financing

Innoviz details $30M registered direct offering, ATM sales and $3.5M defense orders in 6-K update

Innoviz Technologies, an automotive LiDAR supplier, filed a Form 6-K with its management discussion covering recent developments. The company closed a registered direct offering of about 66.7 million shares at $0.45 on July 29, 2026, netting about $27.6 million, and sold shares under its ATM program for about $8.0 million. It also reported initial defense orders of about $3.5 million, a new board chair, and a Nasdaq minimum bid price deficiency notice. The company is not a pharma/biotech business, so the filing carries no drug-specific regulatory content.

12 Nov 2026 · Innoviz Technologies Ltd. INVZ · Company news

Company's press release (SEC filing): Innoviz Technologies Ltd. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →